Bryce Point Capital LLC grew its position in Neogen Corporation (NASDAQ:NEOG – Free Report) by 35.6% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 154,958 shares of the company’s stock after acquiring an additional 40,702 shares during the quarter. Bryce Point Capital LLC owned 0.07% of Neogen worth $741,000 as of its most recent SEC filing.
A number of other hedge funds also recently modified their holdings of the company. Vanguard Group Inc. lifted its position in shares of Neogen by 8.8% in the 1st quarter. Vanguard Group Inc. now owns 23,550,128 shares of the company’s stock worth $204,180,000 after acquiring an additional 1,912,877 shares during the period. Gates Capital Management Inc. bought a new stake in shares of Neogen in the 1st quarter worth approximately $79,391,000. T. Rowe Price Investment Management Inc. lifted its position in shares of Neogen by 18.9% in the 1st quarter. T. Rowe Price Investment Management Inc. now owns 8,458,494 shares of the company’s stock worth $73,336,000 after acquiring an additional 1,343,792 shares during the period. Clarkston Capital Partners LLC lifted its position in shares of Neogen by 118.9% in the 1st quarter. Clarkston Capital Partners LLC now owns 6,276,075 shares of the company’s stock worth $54,414,000 after acquiring an additional 3,409,409 shares during the period. Finally, American Century Companies Inc. lifted its position in shares of Neogen by 16.5% in the 1st quarter. American Century Companies Inc. now owns 3,034,872 shares of the company’s stock worth $26,312,000 after acquiring an additional 428,829 shares during the period. Institutional investors own 96.73% of the company’s stock.
Analyst Ratings Changes
Several research firms recently commented on NEOG. Piper Sandler set a $6.50 target price on Neogen and gave the stock a “neutral” rating in a research report on Thursday, October 16th. William Blair downgraded Neogen from an “outperform” rating to a “market perform” rating in a research report on Tuesday, July 29th. CJS Securities began coverage on Neogen in a research report on Monday, September 29th. They set a “market perform” rating and a $10.00 target price for the company. Wall Street Zen upgraded Neogen from a “hold” rating to a “buy” rating in a research report on Saturday. Finally, Zacks Research upgraded Neogen from a “strong sell” rating to a “hold” rating in a research report on Wednesday, August 20th. One analyst has rated the stock with a Buy rating, four have assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, Neogen currently has a consensus rating of “Hold” and a consensus target price of $8.83.
Neogen Trading Up 1.9%
NEOG stock opened at $6.29 on Tuesday. The business has a fifty day moving average price of $5.81 and a 200 day moving average price of $5.53. Neogen Corporation has a fifty-two week low of $3.87 and a fifty-two week high of $16.79. The stock has a market capitalization of $1.37 billion, a price-to-earnings ratio of -1.31 and a beta of 1.90. The company has a debt-to-equity ratio of 0.37, a current ratio of 3.58 and a quick ratio of 2.26.
Neogen Company Profile
Neogen Corporation, together with its subsidiaries, engages in the development, manufacture, and marketing of various products and services dedicated to food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate, a chemical found in living cells, as well as provides genomics-based diagnostic technology and software systems that help testers to objectively analyze and store their results and perform analysis on the results from multiple locations over extended periods.
Read More
- Five stocks we like better than Neogen
- What is Put Option Volume?
- Semiconductor Supercycle: Why Onsemi Stock Could Double as AI and EV Growth Accelerate
- How is Compound Interest Calculated?
- The Best Local Butchers for Thanksgiving [2025 Survey]
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- $134M in Insider Moves: What It Might Mean for KMI, ISRG and QS
Want to see what other hedge funds are holding NEOG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Neogen Corporation (NASDAQ:NEOG – Free Report).
Receive News & Ratings for Neogen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neogen and related companies with MarketBeat.com's FREE daily email newsletter.
